Bidenoside CCAS# 700877-55-0 |
2D Structure
Quality Control & MSDS
Package In Stock
Number of papers citing our products
Cas No. | 700877-55-0 | SDF | Download SDF |
PubChem ID | N/A | Appearance | Powder |
Formula | C16H22O6 | M.Wt | 310.4 |
Type of Compound | Miscellaneous | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Bidenoside C may have hepatoprotective activity. |
Bidenoside C Dilution Calculator
Bidenoside C Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.2216 mL | 16.1082 mL | 32.2165 mL | 64.433 mL | 80.5412 mL |
5 mM | 0.6443 mL | 3.2216 mL | 6.4433 mL | 12.8866 mL | 16.1082 mL |
10 mM | 0.3222 mL | 1.6108 mL | 3.2216 mL | 6.4433 mL | 8.0541 mL |
50 mM | 0.0644 mL | 0.3222 mL | 0.6443 mL | 1.2887 mL | 1.6108 mL |
100 mM | 0.0322 mL | 0.1611 mL | 0.3222 mL | 0.6443 mL | 0.8054 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 5,7-Dihydroxy-3',4',5'-trimethoxyflavanone
Catalog No.:BCN0136
CAS No.:62252-10-2
- Protocetraric acid
Catalog No.:BCN0135
CAS No.:489-51-0
- Castalin
Catalog No.:BCN0134
CAS No.:19086-75-0
- 3',4',7,8-Tetramethoxyflavone
Catalog No.:BCN0133
CAS No.:65548-55-2
- (+)-Lariciresinol 4'-O-beta-D-Glucopyranosyl-(1->3)-beta-D-glucopyranoside
Catalog No.:BCN0132
CAS No.:639857-95-7
- (-)-Cadin-4,10(15)-dien-11-oic acid
Catalog No.:BCN0131
CAS No.:1124353-23-6
- 2,3-Dehydrosilybin A
Catalog No.:BCN0130
CAS No.:25166-14-7
- Negundoside
Catalog No.:BCN0129
CAS No.:82451-20-5
- Laudanosine
Catalog No.:BCN0128
CAS No.:1699-51-0
- Bacosine
Catalog No.:BCN0127
CAS No.:198014-94-7
- 3',5'-Dimethoxy-4'-hydroxyacetophenone
Catalog No.:BCN0126
CAS No.:2478-38-8
- Fortunellin
Catalog No.:BCN0125
CAS No.:20633-93-6
- Cynatratoside E
Catalog No.:BCN0138
CAS No.:
- Syringetin 3-O-galactoside
Catalog No.:BCN0139
CAS No.:55025-56-4
- (+/-)-2-Methyl-1-butanol
Catalog No.:BCN0140
CAS No.:137-32-6
- 7-Hydroxyflavonol
Catalog No.:BCN0141
CAS No.:492-00-2
- alpha-Bisabolol
Catalog No.:BCN0142
CAS No.:23089-26-1
- cis-Aconitic acid
Catalog No.:BCN0143
CAS No.:585-84-2
- Ergocristine
Catalog No.:BCN0144
CAS No.:511-08-0
- 3',4',7,8-Tetrahydroxyflavone
Catalog No.:BCN0145
CAS No.:3440-24-2
- Daphnin
Catalog No.:BCN0146
CAS No.:486-55-5
- 2',6'-Dihydroxy 4',4-dimethoxydihydrochalcone
Catalog No.:BCN0147
CAS No.:35241-54-4
- 2'-Hydroxyflavanone
Catalog No.:BCN0148
CAS No.:17348-76-4
- 3',4',7-Trihydroxyisoflavone
Catalog No.:BCN0149
CAS No.:485-63-2
Constituents of Coreopsis lanceolata Flower and Their Dipeptidyl Peptidase IV Inhibitory Effects.[Pubmed:32977609]
Molecules. 2020 Sep 23;25(19). pii: molecules25194370.
A new polyacetylene glycoside, (5R)-6E-tetradecene-8,10,12-triyne-1-ol-5-O-beta-glucoside (1), was isolated from the flower of Coreopsis lanceolata (Compositae), together with two known compounds, Bidenoside C (10) and (3S,4S)-5E-trideca-1,5-dien-7,9,11-triyne-3,4-diol-4-O-beta-glucopyranoside (11), which were found in Coreopsis species for the first time. The other known compounds, lanceoletin (2), 3,2'-dihydroxy-4-3'-dimethoxychalcone-4'-glucoside (3), 4-methoxylanceoletin (4), lanceolin (5), leptosidin (6), (2R)-8-methoxybutin (7), luteolin (8) and quercetin (9), were isolated in this study and reported previously from this plant. The structure of 1 was elucidated by analyzing one-dimensional and two-dimensional nuclear magnetic resonance and high resolution-electrospray ionization-mass spectrometry data. All compounds were tested for their dipeptidyl peptidase IV (DPP-IV) inhibitory activity and compounds 2-4, 6 and 7 inhibited DPP-IV activity in a concentration-dependent manner, with IC50 values from 9.6 to 64.9 muM. These results suggest that C. lanceolata flower and its active constituents show potential as therapeutic agents for diseases associated with type 2 diabetes mellitus.
A new sesquiterpene from Kalimeris integrifolia.[Pubmed:28927288]
Nat Prod Res. 2018 May;32(9):1004-1009.
A new sesquiterpene kalinturoside A (1), and 17 known compounds friedelan-3-ol (2), 24-ethyl-5a-cholesta-7, 22(E)-dien-3-one (3), friedelin (4), syringaresinol (5), alpha-spinasterol (6), ciwujiatone (7), syringic acid (8), scopoletin (9), apocynin (10), 1-(3-hydroxy-4, 5-dimethoxyphenyl)ethan-1-one (11), apigenin (12), 5-hydroxymethylfurfural (13), stigmasterol-3-O-beta-d-glucopy-ranoside (14), Bidenoside C (15), citrusin (16), irioresinol A (17) and syringaresinol-4-O-beta-d-glucopyranoside (18) were isolated from the herbs of Kalimeris integrifolia. The structures of these compounds were elucidated using spectroscopic techniques such as NMR and MS. All of the compounds were isolated from this genus for the first time.
Hepato-protective effects and chemical constituents of a bioactive fraction of the traditional compound medicine-Gurigumu-7.[Pubmed:27296281]
BMC Complement Altern Med. 2016 Jun 13;16:179.
BACKGROUND: Gurigumu-7 is an important traditional Mongolian medicine frequently used for liver diseases. However, the pharmacological effects and the bioactive constituents are not well understood. METHOD: This research was to use CCl4-induced liver damage in mice to investigate the hepatoprotective effects of Gurigumu-7 and the methanol eluted fraction from a DIAION column of an extract of Gurigumu-7 (MF). The chemical constituents of MF were analyzed by UPLC-MS. RESULTS: Pretreated orally with MF (66, 132 and 264 mg/kg) once a day for 4 days dose-dependently suppressed CCl4-induced mice liver histopathological changes and serum aminotransferase activities (alanine transaminase: 1144.0 +/- 787.2 v.s. 2461.8 +/- 1072.7 U/L, p < 0.05; aspartate transaminase: 1173 +/- 785.3 v.s. 2506.6 +/- 1140.7 U/L, p < 0.01). MF treated group demonstrated increased levels of SOD (108.19 +/- 30.32 v.s. 75.75 +/- 5.37 U/mg protein, p < 0.01) but decreased levels of malonyldialdehyde (7.68 +/- 1.95 v.s. 44.32 +/- 16.68 nmol/mg protein, p < 0.01) compared to the CCl4 control group. More than 30 chemical constituents were quantified, and MF was found to be rich in ellagic acid (297.97 mg/g), luteolin and its glucosides (35.10 mg/g), apigenin and its glucosides (>30 mg/g), ursolic acid (14.91 mg/g), Bidenoside C (8.75 mg/g), and proanthocyanidins (15.64 mg/g in proanthocyanidin A2 equivalent). CONCLUSION: The methanol eluted fraction (MF) from a DIAION column of an extract of the Mongolian medicine-Gurigumu-7 was found to be more hepatoprotective than Gurigumu-7. The results suggested that MF is a promising bioactive fraction for the development of new hepatoprotective medicine with better formulation and quality control properties.
Quality evaluation of Carthami Flos by HPLC-UV.[Pubmed:24849034]
Arch Pharm Res. 2015;38(5):776-84.
A HPLC-DAD method was developed for simultaneous determination of four marker compounds, kaempferol-3-O-rutinoside, safflomin A, safflomin B and Bidenoside C, in the extract of the flowers of Carthamus tinctorius Linne. Natural samples were extracted in 50% aqueous methanol by ultra-sonication for 60 min. Marker compounds were separated on a C18 column by two-step gradient elution of mobile phase (acetonitrile/water) at a flow rate of 0.75 mL/min and detected at 210 nm. The retention times of safflomin A and safflomin B were shifted according to the pH of the mobile phase. The optimized analytical method was validated to confirm linearity, precision, accuracy and stability of marker compounds. The method was successfully employed to analyze 17 natural samples from different regions, and the data matrix was monitored and visualized by principal component analysis. The assay method could be applied for quality control of the flowers of C. tinctorius Linne.
New acetylenic glucosides from Bidens bipinnata LINNE.[Pubmed:15056959]
Chem Pharm Bull (Tokyo). 2004 Apr;52(4):439-40.
Two new acetylenic glucosides, 8Z-decaene-4,6-diyn-1-O-beta-D-glucopyranoside named Bidenoside C, and 8E-decaene-4,6-diyn-3,10-dihydroxy-1-O-beta-D-glucopyranoside named bidenoside D, have been isolated from the aerial parts of Bidens bipinnata LINNE (Asterceae). These structures have been elucidated on the basis of spectroscopic methods.